## Answer
(model generated chain of thought explanation)

The patient's presentation suggests a condition known as deep vein thrombosis (DVT), which is a blood clot that forms in the deep veins of the leg, typically in the calf or thigh. The symptoms and signs described, such as swelling, redness, warmth, pain, and tenderness, are consistent with DVT.

The patient's history of pregnancy at 35 weeks gestation also raises the possibility of placental thrombosis, which can occur during pregnancy due to changes in blood clotting factors and other physiological changes. Placental thrombosis is a known risk factor for DVT in pregnant women.

Given the patient's presentation and medical history, it is likely that the hormone most implicated in the development of this condition is progesterone. Progesterone levels increase during pregnancy, particularly after 20 weeks gestation, which can lead to changes in blood clotting factors and increase the risk of DVT. Additionally, progesterone has been shown to have anti-thrombotic effects, meaning it may help prevent blood clots from forming.

The other options are less likely:

* Estriol is a form of estrogen that is present during pregnancy, but it is not directly implicated in the development of DVT.
* Human placental lactogen (hPL) is a hormone produced by the placenta that has been shown to have anti-thrombotic effects and may help prevent blood clots from forming.
* Prolactin is a hormone involved in lactation, but it is not directly implicated in the development of DVT.

Therefore, based on the patient's presentation and medical history, the most likely hormone implicated in the development of this condition is progesterone.